The Beijing genotype is associated with young age and multidrug-resistant tuberculosis in rural Vietnam

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 7, 2009, Pages 900-906

  Buu, T N ^a   Huyen, M N ^a   Lan, N T N ^a   Quy, H T ^a   Hen, N V ^b   Zignol, M ^c   Borgdorff, M W ^d   Cobelens, Frank G J ^d,e   Van Soolingen, D ^e  

^a Pham Ngoc Thach Hospital   (Viet Nam)

^b Tien Giang Provincial Tuberculosis and Lung Disease Hospital   (Viet Nam)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Beijing genotype; Drug resistance, multidrug resistant; Tuberculosis; Vietnam

Indexed keywords

BCG VACCINE; ETHAMBUTOL; ISONIAZID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; CHINA; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; POPULATION RESEARCH; PRIORITY JOURNAL; SPUTUM ANALYSIS; SPUTUM CULTURE; VIET NAM;

ADULT; AGE FACTORS; AGED; BCG VACCINE; CHI-SQUARE DISTRIBUTION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; RURAL POPULATION; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; VIETNAM;

EID: 67651208032     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. World Health Organization. Anti-tuberculosis drug resistance in the world. 4th global report. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
2. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545. (Pubitemid 30324196)
3. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12: 736-743.
4. Van Soolingen D, Qian L, de Haas P E, et al. Predominance of a single genotype of M. tuberculosis in countries of East Asia. J Clin Microbiol 1995; 33: 3234-3238.
5. Kremer K, Glynn J R, Lillebaeck T, et al. Definition of the Beijing/W lineage of M. tuberculosis on the basis of genetic markers. J Clin Microbiol 2004; 42: 4040-4049. (Pubitemid 39296121)
6. Anh D D, Borgdorff M W, Van L N, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000; 6: 302-305. (Pubitemid 30396388)
7. Jou R, Chiang C Y, Huang W L. Distribution of the Beijing family genotypes of M. tuberculosis in Taiwan. J Clin Microbiol 2005; 43: 95-100. (Pubitemid 40096285)
8. Krüüner A, Hoffner S E, Sillastu H, et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001; 39: 3339-3345. (Pubitemid 32830336)
9. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant M. tuberculosis clone family. JAMA 1996; 275: 452-457. (Pubitemid 26065618)
10. Almeida D, Rodrigues C, Ashavaid T F, et al. High incidence of the Beijing genotype among multidrug-resistant isolates of M. tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 2005; 40: 881-886. (Pubitemid 40365511)
11. Balabanova Y, Drobniewski F, Fedorin I, et al. The direct observed therapy short course (DOTS) strategy in Samara Oblast, Russian Federation. Respir Res 2006; 7: 44.
12. Glynn J R, Crampin A C, Traore H, et al. Mycobacterium tuberculosis Beijing genotype, northern Malawi. Emerg Infect Dis 2005; 11: 150-153. (Pubitemid 40093373)
13. Li W M, Wang S M, Li C Y, et al. Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000. Int J Tuberc Lung Dis 2005; 9: 1314-1319.
14. Prodinger W M, Bunyaratvej P, Prachaktam R, et al. Mycobacterium tuberculosis isolates of Beijing genotype in Thailand. Emerg Infect Dis 2001; 7: 483-484.
15. Borgdorff M W, van Deutekom H, de Haas P E W, et al. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb) 2004; 84: 337-340.
16. Huong N T, Lan N T, Cobelens F G, et al. Anti-tuberculosis drug resistance in the South of Vietnam: prevalence and trend. J Infect Dis 2006; 194: 1226-1232. (Pubitemid 44630967)
17. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. 313. Geneva, Switzerland: WHO, 2003.
18. International Union Against Tuberculosis and Lung Disease. Technical guide - sputum examination for tuberculosis direct microscopy in low-income countries. 5th ed. Paris, France: The Union, 2000.
19. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 2nd ed. WHO/CDS/TB/2003. 313. Geneva, Switzerland: WHO, 2003.
20. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914. (Pubitemid 27146535)
21. Filliol I, Driscoll J R, van Soolingen D, et al. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol 2003; 41: 1963-1970. (Pubitemid 36576521)
22. Baulch B. Poverty monitoring and targeting using ROC curves: examples from Vietnam. IDS Working Paper 161. Brighton, UK: Institute of Development Studies, 2002.
23. Lan N T N, Lien H T, Tung L B, et al. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 2003; 9: 1633-1635. (Pubitemid 37505466)
24. van Crevel R, Nelwan R H, de Lenne W, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001; 7: 880-883. (Pubitemid 33121597)
25. Sun Y J, Lee A S, Wong S Y, et al. Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol Infect 2006; 134: 329-332. (Pubitemid 43280242)
26. Cox H S, Kubica T, Doshetov D, et al. The Beijing genotype and drug-resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res 2005; 6: 134. (Pubitemid 41645674)
27. Drobniewski F, Balabanova Y, Nikolayevsky V, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005; 293: 2726-2731. (Pubitemid 40965084)
28. World Health Organization. Anti-tuberculosis drug resistance in the world. WHO/TB/97.229. Geneva, Switzerland: WHO, 1997.
29. Lönnroth K, Tran T U, Thuong L M, et al. Can I afford free treatment? Perceived consequences of health care provider choices among people with tuberculosis in Ho Chi Minh City, Vietnam. Soc Sci Med 2001; 52: 935-948. (Pubitemid 32012453)
30. Ministry of Health. HIV/AIDS estimates and projections 2005-2010. Hanoi, Vietnam: Ministry of Health, 2005.